In another recent study by our group (Struckmann et al., 2020), we used a 2-channel fNIRS device to measure the oxy-Hb response during treatment sessions with iTBS over the dmPFC in a sample of patients with depression. This evidence concerns the gene GSTM1 and depressive symptom measurement.